Weekly Print Online Publication Featuring In-Depth Interviews with many of Today's Top Corporate Executives

CEOCFO-Members Login

Become A Member



Business Services   Healthcare   Technology   Consumer  Financial   Capital   Resources   Public Companies    Government Services    Clean Tech    Industrial    Canadian   Global


December 11, 2017 Issue

All rights reserved -



Elysium​ ​Health​ ​CEO,​ ​Eric​ ​Marcotulli,​ ​Wants​ ​to​ ​Solve​ ​the​ Biggest​ ​Challenges​ ​in​ ​Health​ ​-​ ​And Hes​ ​Got​ ​a​ ​Plan​ ​to​ ​Do​ ​It
Eric​ ​Marcotulli - Elysium​ ​Health

CEO  Print Version - PDF  Mobile Download - PDF



Become A Member and Access Full Versions of Interviews Listed Below
Click Here for More Information



Q&A with Guy Lowery, President and CEO of ECOM Medical, Inc. bring to market their Real-Time Endotracheal Cardiac Output Monitoring Smart Device

ECOM Medical, Inc.


Q&A with Stephane Meystre, CEO and Founder of Clinacuity, Inc. adding Intelligence, Functionality and Security to Electronic Health Records

Clinacuity, Inc.


Q&A with Jake Fackrell, CEO of Domega, Inc. acquiring Vast Amounts of Raw, Unstructured, Non-normalized Data then Filtering and Analyzing it for Clients in the Real Estate, Automobile and Fraud Protection Industries

Domega, Inc.


Q&A with Scott Totzke, CEO of ISARA Corporation providing Quantum Age Security and Next Generation Cybersecurity keeping Companies using Cryptography Safe

ISARA Corporation


Q&A with David Medin, CEO of SnapDNA enabling DNA Analysis for Clinical Diagnostics, Food Production and Agricultural Industries while providing Test Results in Less than One Hour



Q&A with Todd D. Wiebusch, CEO of Saebo, Inc. providing Hand and Upper Extremity Rehabilitation Products that help Stroke and other Neurological Injury Patients Regain Lost Function

Saebo, Inc.


Become A Member and Access All Interviews

1 Month Trial $9.99 - 1 Year Membership $50.00
Click Here for More Information




suitX Exoskeletons Increasing Safety and Productivity for Workers in Delivery, Industrial, and Construction and Provides Mobility for Individuals with Spinal Cord Injuries and Stroke


Homayoon Kazerooni, Chief Executive Officer  Print Version - PDF  Mobile Download - PDF  news




Dr. Shahram Rahimi is Awarded a New Patent Entitled: Multicast Routing Protocol for Computing Networks.

Maple Leaf Obtains Foundation Building Permit for its Telkwa, British Columbia Facility


Onconova Therapeutics to Present at the LD Micro Conference in December

Applied BioMath, LLC to Present at the Annual Drug Development Boot Camp


Onconova Therapeutics Announces Data on Improved Formulation of Rigosertib and Next-Generation CDK4/6 Inhibitor at 2017 American Association of Pharmaceutical Scientists Annual Meeting


Onconova Therapeutics Announces Publication of Results from Phase 1/2 Study of Rigosertib in Patients with Myelodysplastic Syndromes (MDS) and MDS Progressed to Acute Myeloid Leukemia

Onconova Therapeutics Announces Pricing of Public Offering of Common Stock


Onconova Therapeutics, Inc. Reports Business Highlights and Third Quarter 2017 Financial Results


Thunder Energies Corporation Final Tests of a Directional Neutron Source for its delivery to a European Customer

Onconova Therapeutics, Inc. to Provide Corporate Update and Third Quarter 2017 Financial Results





CEOCFO Magazine Current Issue, CEO CFO Current Interviews, A Weekly Print Online Publication Featuring In-Depth Interviews with many of Today's Top Corporate Executives, CEO Interviews, Stocks, Financial and Business News, Investor Information! CEO CFO Current Issue, CEO CFO Magazine Latest Issue, Latest CEO Interviews, New Executive Interviews, Interviews with Top Executives


No part of this publication may be reproduced in any form, photocopied or retransmitted or stored in a retrieval system without prior written consent publisher of

Contents of this publication are gathered from sources believed to be reliable, but are not warranted by for any particular use or purpose. does not purchase stock, and the content of this publication may change and may not be deemed as investment advice.